About this trial
This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.
Eligibility criteria
Qualifiers
age ≥ 18 years
Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views
Disqualifiers
age< 18 years
coexistence of other cardiomyopathies or other ≥ moderate valve diseases
scarce acoustic transthoracic echocardiographic window
usual contraindications for cardiac magnetic resonance
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Centro Cardiologico Monzino
Lead sponsor
Humanitas Hospital, Italy
Collaborator
IRCCS Ospedale San Raffaele
Collaborator
Azienda Ulss 2 Marca Trevigiana
Collaborator